Literature DB >> 7790731

Clinical, physiological and anatomical determinants for radiofrequency hyperthermia.

P Wust1, H Stahl, J Löffel, M Seebass, H Riess, R Felix.   

Abstract

Temperature/time curves and corresponding CT scans of > 200 regional heat treatments with the hyperthermia system BSD-2000 in 43 patients have been analysed. In vivo variables and treatment parameters such as local specific absorption rate SAR, local relative SAR parallel SAR parallel, total power P, local cooling coefficients wb, and local steady-state temperature elevations delta Tss (above systemic temperature) have been determined. For determination of wb the well-known and accepted steady-state approach has been used, which was slightly modified for the purposes of this study. Specifically, comparison of cooling coefficients at the beginning and end of heat treatments were performed in tumours and normal tissues. Other variables are anatomical descriptors from CT scans, score of side effects plim, and various clinical factors. A variance analysis of the dependent variables, specifically delta Tss and parallel SAR parallel, is performed with respect to factors which were estimated as predictive. The intratumoral steady-state temperature elevations are determined by the perfusion-related cooling coefficients and local SAR to almost the same extent. Increase of cooling coefficients in tumours during the heat treatment characterizing the thermoregulatory potential have a slight but less important influence with respect to the achieved temperature elevations. SAR is influenced by several anatomical factors which determine the relative SAR distribution and clinical factors which limit the total power P. However, options for controlling present RHT systems in order to optimize the relative SAR distribution or to avoid hot spot phenomena appear limited. Three-dimensional modelling calculations show that the spatial arrangement of electrical interfaces emerging from bone and fat structures limits SAR control in available RHT technology and is mainly responsible for local power-dependent discomfort (Wust et al. 1994b). Some conclusions are drawn, about how technological development of hyperthermia technology can contribute towards overcoming this problem.

Entities:  

Mesh:

Year:  1995        PMID: 7790731     DOI: 10.3109/02656739509022453

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  13 in total

1.  [A phase-I/II study on the local hyperthermia of cervical N2/N3 lymph node metastases].

Authors:  H Stahl; P Wust; R Graf; J Löffel; J Bier; H Riess; V Jahnke; R Felix
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

Review 2.  Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trial.

Authors:  B Rau; P Wust; P Hohenberger; J Löffel; M Hünerbein; C Below; J Gellermann; A Speidel; T Vogl; H Riess; R Felix; P M Schlag
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

3.  [Thermometry by measuring the chemical shift of lanthanide complex].

Authors:  P Konstanczak; P Wust; B Sander; S Schründer; T Frenzel; W Wlodarczyk; T Vogl; G Müller; R Felix
Journal:  Strahlenther Onkol       Date:  1997-02       Impact factor: 4.033

4.  [Phase II study on preoperative radio-chemo-thermotherapy in locally advanced rectal carcinoma].

Authors:  B Rau; P Wust; J Gellermann; W Tilly; M Hünerbein; J Löffel; H Stahl; H Riess; V Budach; R Felix; P Schlag
Journal:  Strahlenther Onkol       Date:  1998-11       Impact factor: 3.621

Review 5.  Blood flow and oxygenation status of human tumors. Clinical investigations.

Authors:  H J Feldmann; M Molls; P Vaupel
Journal:  Strahlenther Onkol       Date:  1999-01       Impact factor: 3.621

6.  Analysis of temperature measurement for monitoring radio-frequency brain lesioning.

Authors:  J Wren; O Eriksson; K Wårdell; D Loyd
Journal:  Med Biol Eng Comput       Date:  2001-03       Impact factor: 3.079

7.  A novel strategy of radiofrequency hyperthermia (neothermia) in combination with preoperative chemoradiotherapy for the treatment of advanced rectal cancer: a pilot study.

Authors:  Hisanori Shoji; Masahiko Motegi; Kiyotaka Osawa; Noriyuki Okonogi; Atsushi Okazaki; Yoshitaka Andou; Takayuki Asao; Hiroyuki Kuwano; Takeo Takahashi; Kyoji Ogoshi
Journal:  Cancer Med       Date:  2015-02-09       Impact factor: 4.452

8.  Pilot study of radiofrequency hyperthermia in combination with gefitinib in gefitinib-effective patients with advanced NSCLC.

Authors:  Yijia Qin; Yu Sun; Yongmei Liu; Yiqiao Luo; Jiang Zhu
Journal:  Thorac Cancer       Date:  2016-03-24       Impact factor: 3.500

9.  Regional hyperthermia of the abdomen, a pilot study towards the treatment of peritoneal carcinomatosis.

Authors:  Marcus Beck; Pirus Ghadjar; Mirko Weihrauch; Susen Burock; Volker Budach; Jacek Nadobny; Jalid Sehouli; Peter Wust
Journal:  Radiat Oncol       Date:  2015-07-30       Impact factor: 3.481

Review 10.  Current state of the art of regional hyperthermia treatment planning: a review.

Authors:  H P Kok; P Wust; P R Stauffer; F Bardati; G C van Rhoon; J Crezee
Journal:  Radiat Oncol       Date:  2015-09-17       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.